Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5449]
News [12650]
Articles [175]
Editorials [5]
Conferences [248]
elearning [17]
Paclitaxel dosing equally effective in preventing breast cancer progression
Dr Andrew Seidman - Memorial Sloan-Kettering Cancer Center, New York, USA
Paclitaxel dosing equally effective in preventing breast cancer progression ( Dr Andrew Seidman - Memorial Sloan-Kettering Cancer Center, New York, USA )
3 Jun 2013
Paclitaxel chemotherapy schedules equally effective for early-stage breast...
Dr G. Thomas Budd - Cleveland Clinic, Cleveland, USA
Paclitaxel chemotherapy schedules equally effective for early-stage breast cancer ( Dr G. Thomas Budd - Cleveland Clinic, Cleveland, USA )
3 Jun 2013
Nintedanib in combination with standard second line therapy in lung cancer
Dr Martin Reck - Hospital Grosshansdorf, Wohrendamm, Germany
Nintedanib in combination with standard second line therapy in lung cancer ( Dr Martin Reck - Hospital Grosshansdorf, Wohrendamm, Germany )
3 Jun 2013
Ganetespib inhibits Hsp90 effective as second-line therapy with docetaxel for...
Dr Suresh S. Ramalingam - Emory University, Atlanta, USA
Ganetespib inhibits Hsp90 effective as second-line therapy with docetaxel for advanced lung cancer ( Dr Suresh S. Ramalingam - Emory University, Atlanta, USA )
3 Jun 2013
Axillary radiotherapy provides alternative to invasive early stage breast...
Dr Emiel J. Rutgers - Netherlands Cancer Institute, Amsterdam
Axillary radiotherapy provides alternative to invasive early stage breast cancer surgery ( Dr Emiel J. Rutgers - Netherlands Cancer Institute, Amsterdam )
3 Jun 2013
Paclitaxel chemotherapy schedules are equally effective for early-stage breast...
Dr G. Thomas Budd - MD Cleveland Clinic, USA
Paclitaxel chemotherapy schedules are equally effective for early-stage breast cancer ( Dr G. Thomas Budd - MD Cleveland Clinic, USA )
3 Jun 2013
Selumetinib, the first effective drug for advanced melanoma of the eye
Dr Richard Carvajal - Memorial Sloan Kettering Cancer Center, New York, USA
Selumetinib, the first effective drug for advanced melanoma of the eye ( Dr Richard Carvajal - Memorial Sloan Kettering Cancer Center, New York, USA )
3 Jun 2013
Extended use of tamoxifen reduces breast cancer recurrence and death
Prof Richard Gray - University of Oxford, Oxford, United Kingdom
Extended use of tamoxifen reduces breast cancer recurrence and death ( Prof Richard Gray - University of Oxford, Oxford, United Kingdom )
2 Jun 2013
Ipilimumab and BRAF inhibitors for advanced melanoma
Dr Lynn Schuchter - University of Pennsylvania, USA
Ipilimumab and BRAF inhibitors for advanced melanoma ( Dr Lynn Schuchter - University of Pennsylvania, USA )
2 Jun 2013
Ten years of tamoxifen superior to five in reducing breast cancer recurrence...
Dr Richard G. Gray - University of Oxford, UK
Ten years of tamoxifen superior to five in reducing breast cancer recurrence and death ( Dr Richard G. Gray - University of Oxford, UK )
2 Jun 2013
Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer
Dr Marcia Brose - Abramson Cancer Center, University of Pennsylvania, USA
Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer ( Dr Marcia Brose - Abramson Cancer Center, University of Pennsylvania, USA )
2 Jun 2013
No survival benefit to adding bevacizumab to standard first-line chemoradiation...
Dr Mark R. Gilbert - University of Texas MD Anderson Cancer Center, Houston, USA
No survival benefit to adding bevacizumab to standard first-line chemoradiation for glioblastoma ( Dr Mark R. Gilbert - University of Texas MD Anderson Cancer Center, Houston, USA )
2 Jun 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation